Basic Information
ID: ALA4702832
Type: ADME
Description: Hepatic clearance in human administered through iv dosing
Format: BAO_0000218
Organism: Homo sapiens
Target: ADMET(ALA612558)
Document: ALA4699523
Hepatic clearance in human administered through iv dosing: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4702832
CL
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 255.27 | 2.29 | 2.29 |
| 494.01 | 3.64 | 3.64 |
| 206.28 | 3.07 | 3.07 |
| 515.10 | 6.48 | 6.48 |
| 296.15 | 4.36 | 4.36 |
| 408.47 | 2.68 | 2.68 |
| 586.20 | 8.95 | 8.95 |
| 230.26 | 3.04 | 3.04 |
| 501.67 | 5.51 | 5.51 |
| 551.63 | 4.20 | 4.20 |
| 514.63 | 7.26 | 7.26 |
| 435.53 | 4.16 | 4.16 |
| 445.55 | 2.08 | 2.08 |
| 411.47 | 4.63 | 4.63 |
| 424.53 | 2.44 | 2.44 |
| 399.58 | 5.10 | 5.10 |
| 452.60 | 5.22 | 5.22 |
| 527.64 | 3.52 | 3.52 |
| 459.56 | 4.88 | 4.88 |
| 558.65 | 6.31 | 6.31 |
| 481.55 | 2.40 | 2.40 |
| 428.54 | 4.78 | 4.78 |
| 731.84 | 3.14 | 3.14 |
| 461.39 | 4.01 | 4.01 |
| 421.47 | 4.52 | 4.52 |
| 406.24 | 5.40 | 5.40 |
| 501.66 | 4.22 | 4.22 |
| 541.06 | 5.00 | 5.00 |
| 531.90 | 5.40 | 5.40 |
| 500.36 | 5.15 | 5.15 |
| 436.92 | 3.11 | 3.11 |